Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Damle SS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carrer M; Department of Antisense Drug Discovery., Crosby JR; Department of Antisense Drug Discovery., Sun G; Department of Antisense Drug Discovery., Zhao C; Department of Antisense Drug Discovery., Damle SS; Department of Functional Genomics., Kuntz SG; Department of Functional Genomics., Monia BP; Department of Business Operations, and., Hart CE; Department of Functional Genomics., Grossman TR; Department of Translational Medicine, Ionis Pharmaceuticals, Inc., Carlsbad, California.
Publikováno v:
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2020 Jul; Vol. 63 (1), pp. 46-56.
Autor:
Lai F; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA. Electronic address: flai@ionisph.com., Damle SS; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA., Ling KK; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA., Rigo F; Ionis Pharmaceuticals, Carlsbad, CA 92010, USA. Electronic address: frigo@ionisph.com.
Publikováno v:
Molecular cell [Mol Cell] 2020 Mar 05; Vol. 77 (5), pp. 1032-1043.e4. Date of Electronic Publication: 2020 Jan 07.
Autor:
Cho CE; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA. ccho@ionisph.com., Damle SS; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Wancewicz EV; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Mukhopadhyay S; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Hart CE; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Mazur C; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Swayze EE; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA., Kamme F; Ionis Pharmaceuticals, Inc, Carlsbad, CA, 92010, USA.
Publikováno v:
BMC genomics [BMC Genomics] 2019 Feb 28; Vol. 20 (1), pp. 164. Date of Electronic Publication: 2019 Feb 28.
Autor:
Huang L; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Low A; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Damle SS; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Keenan MM; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Kuntz S; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Murray SF; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Monia BP; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Guo S; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA. sguo@ionisph.com.
Publikováno v:
Genome biology [Genome Biol] 2018 Jan 15; Vol. 19 (1), pp. 4. Date of Electronic Publication: 2018 Jan 15.
Autor:
Liang XH; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Sun H; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Shen W; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Wang S; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Yao J; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Migawa MT; Department of Medicinal Chemistry, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Bui HH; Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Damle SS; Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Riney S; Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Graham MJ; Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Crooke RM; Department of Antisense Drug Discovery, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA., Crooke ST; Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad, CA, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2017 Sep 19; Vol. 45 (16), pp. 9528-9546.
Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment.
Autor:
Kueh HY; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Yui MA; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Ng KK; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Pease SS; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Zhang JA; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Damle SS; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Freedman G; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Siu S; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA., Bernstein ID; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Elowitz MB; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.; Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California, USA., Rothenberg EV; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Publikováno v:
Nature immunology [Nat Immunol] 2016 Aug; Vol. 17 (8), pp. 956-65. Date of Electronic Publication: 2016 Jul 04.
Autor:
Patel PP; Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Datta MK; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Center for Complex Engineered Multifunctional Materials, University of Pittsburgh, PA 15261, USA., Velikokhatnyi OI; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Center for Complex Engineered Multifunctional Materials, University of Pittsburgh, PA 15261, USA., Kuruba R; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Damodaran K; Department of Chemistry, University of Pittsburgh, PA 15260, USA., Jampani P; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Gattu B; Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Shanthi PM; Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Damle SS; Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Kumta PN; Department of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.; Center for Complex Engineered Multifunctional Materials, University of Pittsburgh, PA 15261, USA.; Mechanical Engineering and Materials Science, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.; School of Dental Medicine, University of Pittsburgh, PA 15217, USA.
Publikováno v:
Scientific reports [Sci Rep] 2016 Jul 06; Vol. 6, pp. 28367. Date of Electronic Publication: 2016 Jul 06.
Autor:
Lima WF; Department of Core Antisense Research, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Murray HM; Department of Core Antisense Research, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Damle SS; Department of Functional Genomics, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Hart CE; Department of Functional Genomics, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Hung G; Department of Antisense Drug Discovery, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., De Hoyos CL; Department of Core Antisense Research, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Liang XH; Department of Core Antisense Research, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Crooke ST; Department of Core Antisense Research, Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA scrooke@ionisph.com.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2016 Jun 20; Vol. 44 (11), pp. 5299-312. Date of Electronic Publication: 2016 Apr 29.
Autor:
Huang L; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Damle SS; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Booten S; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Singh P; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Sabripour M; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Hsu J; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Jo M; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Katz M; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Watt A; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Hart CE; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Freier SM; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Monia BP; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America., Guo S; Department of Antisense Drug Discovery, Isis Pharmaceuticals Inc., Carlsbad, CA, 92010, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Jul 24; Vol. 10 (7), pp. e0132798. Date of Electronic Publication: 2015 Jul 24 (Print Publication: 2015).